Geode Capital Management, LLC Mi Nk Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 97,981 shares of INKT stock, worth $50,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,981
Previous 96,347
1.7%
Holding current value
$50,950
Previous $91,000
19.78%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INKT
# of Institutions
29Shares Held
848KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$121,7740.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$86,6660.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny107KShares$55,4770.0% of portfolio
-
Black Rock Inc. New York, NY87.2KShares$45,3410.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL51.7KShares$26,8980.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $17.6M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...